U.S., July 12 -- ClinicalTrials.gov registry received information related to the study (NCT07060547) titled 'Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver Disease' on May 13.
Brief Summary: This is a study to measure liver recovery in patients with recent alcohol-associated liver injury by assessing liver function and physiology using HepQuant DuO. The HepQuant DuO Test is a blood-based test that involves a drink of a natural compound, cholate, and 2 blood samples at 20 and 60 minutes. The study team is collecting clinical and laboratory data to better monitor and treat patients who have been affected by alcohol-associated liver disease. The study has 4 visits at an outpatient clinic at 1, 3, 6, and 12 months. At ...